Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_707fed4a1a60fa61a1abd576112d5c64 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P23-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-54 |
filingDate |
2019-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6d694aa0da625443910a14e2550eee6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3157cfc5fa1fc3a67e51e0353239fbf8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3fa9da90ee5845ba2f32495ef3c2eb7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1655da041a0e0db748ebb3c5a23af72a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_826c5debc944ae7d7b1fc8996640e976 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea9f8187f592dcc6cb603de20acfb4c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f33ad3f54d9d5d2faad858114adb372b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32351fb992dd42f37396cde9d2ab6a95 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77cbcf2d22c49fbb2b87780e975c4e31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af3098942f62dee12e47bcfb7940f1e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16d502fcc84e3a02a886d46d90cfefa5 |
publicationDate |
2020-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2712916-C1 |
titleOfInvention |
Method of anesthesia in balb/c nude mice in surgical interventions |
abstract |
FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to experimental oncology, and is intended for anesthesia in Balb/c Nude mice in surgical interventions. Method of anesthesia in Balb/c Nude mice in surgical interventions involves xylazine premedication intramuscularly and anesthesia with the help of "Zoletil 100", which is administered intramuscularly. A preparation of xylazine with concentration of 20 mg/ml is introduced in dose of 1.5 ml/kg. In 15 minutes after pre-medication preparation "Zoletil 100" is introduced in the form of aqueous solution with concentration of 22.57 mg/ml in dose of 67.5 mg/kg of body weight of Balb/c Nude mice.EFFECT: use of the invention provides humane treatment of Balb/c Nude mice in surgical interventions due to optimal depth of anesthesia and minimal toxic effect on the body of mice.1 cl, 1 ex |
priorityDate |
2019-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |